Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Kumar M, Abbas Z, Azami M, Belopolskaya M, Dokmeci AK, Ghazinyan H, et al. Asian pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy. Hep Intl. 2022;16(2):211–253
2. Zeng QL, Yu ZJ, Ji F, Li GM, Zhang GF, Xu JH, et al. Tenofovir alafenamide to prevent perinatal hepatitis B transmission: a multicenter, prospective. Observational Study Clin Infect Dis. 2021;73(9):e3324–e3332
3. Zeng QL, Zhang HX, Zhang JY, Huang S, Li WZ, Li GM, et al. Tenofovir alafenamide for pregnant chinese women with active chronic hepatitis B: a multicenter prospective study. Clin Gastroenterol Hepatol. 2021. https://doi.org/10.1016/j.cgh.2021.12.012
4. Ding Y, Cao L, Zhu L, Huang Y, Lin C, Wang Y, et al. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study. Aliment Pharmacol Ther. 2020;52(8):1377–1386
5. Li B, Liu Z, Liu X, Liu D, Duan M, Gu Y, et al. Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load. Hepatol Int. 2021;15(5):1103–1108